|Bid||3.8200 x N/A|
|Ask||3.9800 x N/A|
|Day's Range||3.7500 - 3.9900|
|52 Week Range||2.8400 - 14.4000|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / November 18, 2021 /IM Cannabis Corp. (the "Company" or "IM Cannabis") (CSE:IMCC)(NASDAQ:IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Germany and Canada, today announced the fourth installment of shares in connection with the previously announced acquisition of the Panaxia-to-the-Home online pharmacy and trading centre with an IMC-GDP license from Panaxia Pharmaceutical Industries Israel Ltd.
4 million; a 30% increase from Q2 2021Gross margin improved to 20% from 5.4% in Q2 2021; expected to increase further in Q4 and into 2022Canadian recreational brands WAGNERS and Highland Grow continue to gain market share, with sales in Ontario from June to October increasing by over 110%TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / November 15, 2021 / IM Cannabis Corp.
Last year, the Democratic Party won a major electoral victory at the upper Federal levels, taking control of the White House and the US Senate, while retaining control of the House of Representatives. Their control of Congress rests on thin margins – but it is a legislative majority, and it held out high hopes of real policy shifts from the Trump Administration. Cannabis investors, especially, were pleased, as the Democrats are seen as far more likely to legalize the substance at the Federal lev